Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of CS-3150 in Type 2 Diabetes Mellitus Patients with Albuminuria
jRCT2080221972Phase 2
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of esaxerenone in type 2 diabetes mellitus (T2DM), hypertension (HTN) and diabetic glomerulosclerosis, sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
esaxerenone
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)diabetic glomerulosclerosis
Beyond the preview
Go deeper on jRCT2080221972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221972.